Category: Autoimmune
Global Autoimmune
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030 Given ... Read More
-
2023 Global Autoimmune Disease Diagnosis Market Industry (2029 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Global Neuromyelitis Optica Spectrum Disorder Market 2023-2027
... on the neuromyelitis optica spectrum disorder market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, Others), by End User(Hospitals & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030
... & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030 Global Plasma Fractionation Market is valued approximately USD 30.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% ... Read More
-
Specialty Generics Market Forecasts to 2028 – Global Analysis By Type (Oral Drugs, Injectables, Topical, Parenteral and Other Types), By Application (Hepatitis C, Multiple Sclerosis, Inflammatory Conditions, Oncology, Cardiovascular, Infectious Diseases, Autoimmune Diseases and Other Applications), By End User and By Geography
... Applications), By End User and By Geography According to Stratistics MRC, the Global Specialty Generics Market is accounted for $69.9 billion in 2022 and is expected to reach $176.6 billion by 2028 growing at a ... Read More
-
Global Eosinophilic Esophagitis Drug Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. Eosinophilic esophagitis was first described in children but also occurs in ... Read More
-
Clinical Trials Market Analysis and Forecast to 2032: By Phase (Phase I, Phase II, Phase III, and Phase III), Study Design (Interventional Study, Observational Study, and Expanded Access Study), Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, and Others), and Region
... and Others), and Region A clinical trial is a research study that tests a new medical approach, device, medication, or other treatment. Clinical trials are used to determine whether new medical approaches are safe and ... Read More
-
Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028
... reach USD 4.7 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 7.4% during the forecast period of 2023 to 2028. Market growth is largely driven by increased prevalence of cancer ... Read More
-
Global Systemic Lupus Erythematosus Market - 2023-2030
... by 2030. The systemic lupus erythematosus market is expected to exhibit a CAGR of 7.3% during the forecast period (2023-2030). Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can harm the skin, joints, ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Global Eosinophilic Esophagitis Drug Market Research Report 2023(Status and Outlook)
... a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food ... Read More
-
Global Systemic Lupus Erythematosus SLE Drugs Market Research Report 2023(Status and Outlook)
... and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system ... Read More
-
Global Liver Disease Treatment Market Size study & Forecast, by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others) and Regional Analysis, 2022-2029
... Others) and Regional Analysis, 2022-2029 Global Liver Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the ... Read More
-
Global Oral Transmucosal Drugs Market - 2023-2030
... by 2030. The oral transmucosal drugs market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030). Globally, chronic or non-communicable diseases are on the rise and are responsible for 73% of ... Read More
-
Global Difficult-to-Express Proteins Market - 2023-2030
... is expected to exhibit a CAGR of 11.0% during the forecast period (2023-2030). Key strategy acquisitions drive the difficult-to-express proteins market growth. For instance, the acquisition of BioLegend, a top global supplier of life science ... Read More
-
Autoimmune Disease Diagnostics Market Forecasts to 2028 – Global Analysis By Disease Type (Localized Autoimmune Disease, Systemic Autoimmune Disease), Test Type (C-reactive Protein (CRP) Test, Antinuclear Antibody Test, Complete Blood Count (CBC), Urinalysis, Erythrocyte Sedimentation Rate (ESR), Comprehensive Metabolic Panel, Biopsy) and Others
... Rate (ESR), Comprehensive Metabolic Panel, Biopsy) and Others According tStratistics MRC, the Global Autoimmune Disease Diagnostics Market is accounted for $1198.9 billion in 2022 and is expected treach $1966.8 billion by 2028 growing at a ... Read More
-
Immunoglobulins: Global Market Outlook
... report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market. In terms of geographical regions, the report analyzes the market across North ... Read More
-
Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
... Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others) The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 ... Read More
-
Global Biologicals for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologicals for Systemic Lupus Erythematosus sales for 2023 through 2029. With Biologicals for Systemic Lupus Erythematosus sales ... Read More
-
Global Glucocorticoid for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Glucocorticoid for Systemic Lupus Erythematosus sales for 2023 through 2029. With Glucocorticoid for Systemic Lupus Erythematosus sales ... Read More
-
Global Immunosuppressant for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunosuppressant for Systemic Lupus Erythematosus sales for 2023 through 2029. With Immunosuppressant for Systemic Lupus Erythematosus sales ... Read More
-
Global Systemic Lupus Erythematosus (SLE) Drugs Market Growth 2023-2029
... for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and ... Read More
-
Global Autoimmune Disorders Treatment Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Autoimmune Disorders Treatment sales for 2023 through 2029. With Autoimmune Disorders Treatment sales broken down by region, market sector and sub-sector, this report ... Read More
-
Global Animal Autoimmune Diseases Testing Market Growth (Status and Outlook) 2023-2029
... the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition. Sometimes, autoimmune cells will get activated due to molecular imitation between pathological antigens and self. Animal ... Read More
Research Assistance
